Accredo
HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Cerezyme® (imiglucerase) - overview

Cerezyme® (imiglucerase)

Overview | Product information | Accredo services | Contact team


Gaucher disease is an inherited genetic condition that causes fatty deposits to build up in certain organs and bones. People with Gaucher disease do not have enough of the enzyme glucocerebrosidase that helps the body to break down a certain type of fat molecule, glucocerebroside. As a result, cells fill up with the undigested fat. These cells are referred to as Gaucher cells. Learn more about our Gaucher disease therapy management.

The course of the disease is quite variable. The most common symptoms of Gaucher disease are enlargement of the liver and spleen, anemia, reduced platelets (resulting in easy bruising and long clotting times), bone pain, bone infarctions often leading to damage to the shoulder or hip joints, and a generalized demineralization of the bones (osteoporosis). The weakening of the bones can then lead to spontaneous fractures.

Accredo has been working with lysosomal storage disorder (LSD) therapies since 1991 and has gained extensive experience that serves as a valuable resource to our patients.

Referrals

Other Resources:

Cerezyme.com

Genzyme Corporation

National Gaucher Foundation

NORD - National Organization for Rare Diseases


Cerezyme is a registered trademark of Genzyme Corporation

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us